QA Directives
NQAS
| Sl No | Title Description | View/Download |
|---|---|---|
| 41 | MusQan Implementation Roadmap, 6 January 2022 | |
| 42 | NQAS Internal Assessors ToT | |
| 43 | Letter for roll out of QA under SUMAN | |
| 44 | TISS Training Course, 2021 | |
| 45 | Dissemination letter of NQAS Operational Guidelines, 2021 | |
| 46 | DO Secretary (HFM) Letter Regarding Targets For NQAS Certification Of Public Health Facilities | |
| 47 | Surveillance Audit | |
| 48 | Mera Aspataal DO | |
| 49 | Revised Validity of “Certified with conditionality” under NQAS and LaQshya 03.12.2020 | |
| 50 | NQAS_LaQshya_Additional_documents |
LaQshya
Kayakalp
NUHM
Free Drugs Service Initiative
| S.No. | Title Description | View/Download |
|---|---|---|
| 1 | Letter for Launch of Free Drugs Service Initiative under NHM | |
| 2 | Letter to request to provide information from all StatesUTs pertaining to all components of FDSI guideline | |
| 3 | AS & MD Letter to states for implementation of DVDMS up to drug distribution counter level | |
| 4 | JS(P) Letter for inclusion of iron chelating agents in DH & SDH EML | |
| 5 | JS(P) Letter to states to follow IPHS EML | |
| 6 | AS & MD Letter for Inclusion of Hydroxyure, Coagulation Factors and ARS in the EML | |
| 7 | HFM Letter to all StatesUTs CM for implementation of Drugs and Diagnostics | |
| 8 | Letter to all StatesUTs to update the nomenclature of PHC and SHC as AAM-PHC and AAM-SHC | |
| 9 | DO-States - To Update Nomenclature of Facilities on DVDMS as Per IPHS | |
| 10 | Forms & Formats | |
| 11 | Ministry Letters |
